Skip to main content

ORIGINAL RESEARCH article

Front. Neurol.
Sec. Headache and Neurogenic Pain
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1406602
This article is part of the Research Topic Headache and other symptoms in special populations View all 17 articles

Comparison of Microvascular Decompression and Percutaneous Balloon Compression Efficacy in Patients with V2 Idiopathic Trigeminal Neuralgia

Provisionally accepted
Ye Ji Ye Ji 1Junwu Wang Junwu Wang 2*
  • 1 Sheng Jing Hospital Affiliated, China Medical University, Shenyang, Liaoning Province, China
  • 2 Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China

The final, formatted version of the article will be published soon.

    Objective: This study aims to compare the efficacy and long-term prognosis of microvascular decompression (MVD) versus percutaneous balloon compression (PBC) in patients with idiopathic V2 (maxillary branch) trigeminal neuralgia.We retrospectively analyzed the clinical information and follow-up data of patients who underwent surgical treatment for V2 idiopathic trigeminal neuralgia from January 2020 to January 2023. A total of 58 patients were included in the MVD group and 99 in the PBC group. All surgeries were performed by two physicians at the same center, with follow-up conducted by a separate, trained researcher. We compared the initial versus 12-month postoperative pain relief rates (scored using the BNI), surgical complications, and described pain relief rates after long-term follow-up in both groups using Kaplan-Meier analysis.The study included a total of 157 patients (MVD 58, PBC 99). The median age of patients in the MVD group was lower than that in the PBC group (58 [51-65] vs 63 [58-69], p=0.002). There was no significant difference between the two groups in terms of pain relief rates initially after surgery and at 12 months (p=0.521, p=0.713). However, the MVD group had significantly better outcomes regarding postoperative facial numbness (p<0.0001), masticatory weakness (p=0.0017), and other complications (p=0.04). Kaplan-Meier analysis showed that MVD provided a longer duration of pain relief than PBC (p=0.0323), with most recurrences in both groups occurring within 1-2 years after surgery.There were no significant differences in significant pain relief rates between the two groups initially after surgery and at 12 months. However, the MVD group showed a clear advantage over PBC regarding postoperative facial numbness, masticatory weakness, and other complications; moreover, Kaplan-Meier analysis revealed that MVD offers a longer duration of pain relief for patients.

    Keywords: Trigeminal Neuralgia, Microvascular decompression, Percutaneous balloon compression, Idiopathic, therapeutic effectiveness

    Received: 25 Mar 2024; Accepted: 02 Oct 2024.

    Copyright: © 2024 Ji and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Junwu Wang, Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.